Register for email alerts and news feeds:
This journal | BMJ Group
rss
Published Online First: 14 June 2006. doi:10.1136/jcp.2005.032391
Journal of Clinical Pathology 2007;60:415-418
Copyright © 2007 by the BMJ Publishing Group Ltd & Association of Clinical Pathologists.

ORIGINAL ARTICLE

Hepatic expression of galectin-3 and receptor for advanced glycation end products in patients with liver disease

M Butscheid1, P Hauptvogel2, P Fritz2, U Klotz1 and D M Alscher3

1 Dr Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany
2 Division of Pathology, Department of Diagnostic Medicine, Robert Bosch Krankenhaus, Stuttgart, Germany
3 Division of General Internal Medicine and Nephrology, Robert Bosch Krankenhaus, Stuttgart, Germany

Correspondence to:
Correspondence to:
Dr M Butscheid
Paumgartnerstr 15, 90429 Nürnberg, Germany;dr.m.butscheid{at}email.de

Background: Advanced glycation end products (AGEs) are a heterogeneous group of glycosylated proteins (of which carboxymethyl-lysine (CML) is the most common) which accumulate during ageing processes and play an important role in the pathogenesis of a variety of chronic diseases. Impaired hepatic function might result in elevated levels of AGEs, as the liver represents the major site of AGE metabolism. The actions of AGEs are mediated by various receptors, among which the AGE-receptor complex (including galectin-3 as an essential part) is thought to have a cytoprotective effect, and receptor for advanced glycation end product (RAGE) a cytotoxic effect.

Aim: To assess the relationship between CML and expression of galectin-3 and RAGE in different histological structures in biopsy specimens from patients with varying degrees of liver impairment.

Method: Immunohistochemical staining of 164 biopsies from patients with varying degrees of liver impairment was performed to determine the levels of CML, galectin-3 and RAGE in hepatocytes, Kupffer cells and bile ducts by a semiquantative score.

Results: Independent of diagnosis, CML and RAGEs were detected in hepatocytes, whereas galectin-3 was present only in hepatocytes of cirrhotics. By contrast, CML and galectin-3 were highly expressed in Kupffer cells (well correlating levels, highest scores in cholestasis) whereas expression of RAGEs was not significant. All three assessed biochemical markers showed their highest levels of expression/detection in bile ducts.

Conclusion: These findings indicate an increased susceptibility of hepatocytes to the detrimental effects of AGEs and underline the protective function of Kupffer cells. Furthermore, the biliary system seems to play an important role in the disposition of AGEs.

Abbreviations: AGE, advanced glycation end product; CML, carboxymethyl-lysine; RAGE, receptor for advanced glycation end product


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Pathology jobs

Pathology jobs